Latest News

Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 Second Quarter Financial Results and Provide Corporate Business Update

Date: July 14, 2021 | READ MORE >

Ampio Pharmaceuticals Announces Patient Randomization and Dosing in AP-019 Phase II Study of Inhaled Ampion in COVID-19 Respiratory Distress

Date: June 25, 2021 | READ MORE >

Ampio Pharmaceuticals, Inc. to Join the Russell 2000® Index and Russell 3000® Index

Date: June 18, 2021 | READ MORE >

Ampio Provides Update on Osteoarthritis of the Knee (OAK) Program, Reiterates Compelling Data in Earlier Phase III Trials of Ampion in Severe OAK

Date: June 17, 2021 | READ MORE >

Ampio Pharmaceuticals Receives Approval to Expand Enrollment of its AP-019 Phase II Study to India

Date: June 15, 2021 | READ MORE >

Ampio Pharmaceuticals to Participate in the Alliance Global Partners’ Virtual Summer Healthcare Symposium

Date: June 14, 2021 | READ MORE >

Ampio Pharmaceuticals to Present at the 2021 International Society for Pharmaceutical Engineers Annual Meeting and Expo

Date: June 14, 2021 | READ MORE >

Ampio Pharmaceuticals to Present Poster at the International Society for Aerosols in Medicine (ISAM) 23rd International Congress

Date: May 21, 2021 | READ MORE >

Ampio Pharmaceuticals Receives Investigational Review Board Approval for its Phase I Long COVID-19 Trial (AP-018)

Date: May 10, 2021 | READ MORE >

Ampio Pharmaceuticals, Inc. Reports First Quarter 2021 Financial Results and Provides Business Update

Date: May 5, 2021 | READ MORE >

Ampion™ Reduces All-cause Mortality in COVID-19 Respiratory Distress by Nearly 80%

Date: April 27, 2021 | READ MORE >

Ampio Pharmaceuticals Provides Updates on Clinical Programs for Ampion™ in Osteoarthritis and COVID-19

Date: April 27, 2021 | READ MORE >

Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business Update

Date: April 21, 2021 | READ MORE >

Research Shows Ampion™ Gene Regulation Mimics the Anti-Inflammatory Effects of Steroids, but without Adverse Effects

Date: April 19, 2021 | READ MORE >

Ampio Pharmaceuticals’ Study Shows Ampion Inhibits a Key Inflammatory Pathway in COVID-19 and Lupus Nephritis

Date: April 6, 2021 | READ MORE >

Ampio Pharmaceuticals to Present at the International Society for Aerosols in Medicine (ISAM) 23rd International Congress

Date: March 29, 2021 | READ MORE >

Ampio Pharmaceuticals to Present at Benzinga Biotech Small Cap Conference

Date: March 19, 2021 | READ MORE >

Ampio Pharmaceuticals Details Early Positive Results for Inhaled Ampion in COVID-19 Respiratory Distress

Date: March 16, 2021 | READ MORE >

Ampio Pharmaceuticals to Participate in the 33rd Annual Virtual ROTH Conference on March 15-17, 2021

Date: March 10, 2021 | READ MORE >

Ampio Pharmaceuticals, Inc. Reports Fourth Quarter 2020 Financial Results and Provides Business Update

Date: March 3, 2021 | READ MORE >